Companies  » Health Care

Govt caps prices of 36 more drugs

Govt has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines ...

Apollo Hospitals eyeing higher margins

18 Sep 2014

While HMS acquisition will add to company's pharmacy business, hospital segment will drive profits

Cipla, Salix Pharma sign patent out-licensing deal

18 Sep 2014

Mumbai-based Cipla has signed an agreement with American company Salix Pharmaceuticals, under which Cipla has granted Salix exclusive rights ...

Sun Pharma gains 2% on pact with Merck & Co for Tildrakizumab

18 Sep 2014

Sun Pharma has entered into a licensing agreement with Merck & Co Inc for investigational therapeutic antibody candidate, Tildrakizumab.

Lupin: Correction an opportunity

17 Sep 2014

While Merck Sereno and Salix deals will add to earnings in long run, existing geographies will continue driving growth

Sun Pharma, Merck & Co enter agreement for Tildrakizumab

17 Sep 2014

The US-based Merck & Co., Inc. and Sun Pharmaceuticals have entered into an exclusive worldwide licensing agreement for Merck's dermatology ...

Ranbaxy says US authorities seek information on pricing data

17 Sep 2014

The data has been sought for some products eligible for reimbursement under the Medicaid program

We want to be like oxygen to AstraZeneca and then we can focus on innovation: David Smoley

17 Sep 2014

Q&A with Chief Information Officer, AstraZeneca

Piramal to sell diagnostics equipment trading unit to DiaSys

17 Sep 2014

The deal is worth Rs 13 cr

Apollo Hospitals up on plan to buy Hetero Pharmacy

17 Sep 2014

The company plans to acquire 320 Hetero Pharmacy stores for a consideration of Rs 146 crore

Apollo Hospitals acquires Hetero Pharmacy assets for Rs 146 cr

17 Sep 2014

Apollo Hospitals Enterprise Ltd (AHEL) has announced acquisition of Hyderbad-based pharmacy chain Hetero Med Solutions Ltd (HMSL) for a ...

Aurobindo Pharma gains after USFDA nod

17 Sep 2014

Aurobindo Pharma has gained after receiving final approval from USFDA to manufacture and market Amoxicilin

Lupin extends losses in an otherwise firm market

17 Sep 2014

Lupin has dipped 1% extending its yesterday's decline of 5%, after entering into a partnership with Merck Serono,

Lupin, Merck Serono join hands to tap emerging markets

17 Sep 2014

Lupin will develop products, provide product dossiers and supply finished products to Merck Serono

Aurobindo gets USFDA approval for anti-infection drug

16 Sep 2014

Aurobindo Pharma Limited today announced that it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and ...

Pharma major AstraZeneca launches IT facility in Chennai

16 Sep 2014

The company is planning to bring down the IT spend on outsourcing from 70% to 30% in three years

Lupin inks deal with Merck Serono; stock tanks 6%

16 Sep 2014

The stock has seen a strong run-up ahead of announcement, rallied 9.3% from Rs 1,319 in past three trading sessions.

Venus Remedies tanks on profit bookings

16 Sep 2014

The stock tanked 12% after surged 36% in past nine trading sessions.

We're not always at loggerheads with innovator companies: Denis Broun

16 Sep 2014

Interview with Global Director for Access and Public Affairs, Cipla Global

Quick Links


Back to Top